Bispecific Antibodies in Multiple Myeloma | Dana-Farber Cancer Institute
6 Views
administrator
07/14/23
Omar Nadeem, MD, explains bispecific antibodies as an exciting new immunotherapy treatment option for patients with relapsed or refractory multiple myeloma. Learn more about our Multiple Myeloma Program. https://www.dana-farber.org/mu....ltiple-myeloma-progr
-
Category
Show more
Facebook Comments
No comments found